• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在未经筛选的心力衰竭人群中选择心脏再同步治疗(CRT)的患者。

Selection of patients for cardiac resynchronisation therapy (CRT) in an unselected heart failure population.

作者信息

Lucas C M H B, Cleuren G V J, Kirchhof C J H J

出版信息

Neth Heart J. 2006 Jan;14(1):14-18.

PMID:25696549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2557224/
Abstract

BACKGROUND

In patients with chronic heart failure (CHF), the presence of conduction delay across the myocardium is a well-known feature. During recent years an increasing number of CHF patients have been treated with cardiac resynchronisation therapy (CRT). So far in many protocols patients have been selected using the criteria of left ventricular ejection fraction (LVEF) ≤35% concomitant with signs of widening of the QRS on the surface electrocardiogram, either with or without left bundle branch block (LBBB) morphology.

METHODS

In this article we discuss which of the patients admitted with CHF to a regular cardiology practice could be candidates for this therapy. Data were obtained from January 2000 to December 2004 on a total of 861 CHF patients, of whom 309 had an LVEF ≤35%. Of these patients, 123 patients showed a QRS width >120 msec, while 81 patient had a QRS width >140 msec. In total, 89 patients had an LBBB morphology on the electrocardiogram, while 21 patients had univentricular pacing devices in situ. In those patients with an LVEF >35%, QRS width was 108±27msec.

CONCLUSION

A substantial number of patients presenting with CHF in a regular cardiology practice are suitable candidates for CRT therapy according to currently used criteria of QRS width and LVEF. This number could be increased even more if recent information concerning intraventricular conduction delay in CHF patients with less widening of the QRS complex were to be applied, as judged by echocardiographic techniques.

摘要

背景

在慢性心力衰竭(CHF)患者中,心肌传导延迟的存在是一个众所周知的特征。近年来,越来越多的CHF患者接受了心脏再同步治疗(CRT)。到目前为止,在许多方案中,患者是根据左心室射血分数(LVEF)≤35%以及体表心电图上QRS波增宽的体征来选择的,无论有无左束支传导阻滞(LBBB)形态。

方法

在本文中,我们讨论了在普通心脏病科就诊的CHF患者中哪些可能是这种治疗的候选者。数据收集于2000年1月至2004年12月,共861例CHF患者,其中309例LVEF≤35%。在这些患者中,123例QRS波宽度>120毫秒,81例QRS波宽度>140毫秒。总共有89例患者心电图呈LBBB形态,21例患者已植入单心室起搏装置。在LVEF>35%的患者中,QRS波宽度为108±27毫秒。

结论

根据目前使用的QRS波宽度和LVEF标准,在普通心脏病科就诊的大量CHF患者是CRT治疗的合适候选者。如果应用有关QRS波群增宽较小的CHF患者室内传导延迟的最新信息(通过超声心动图技术判断),这个数字可能会进一步增加。

相似文献

1
Selection of patients for cardiac resynchronisation therapy (CRT) in an unselected heart failure population.在未经筛选的心力衰竭人群中选择心脏再同步治疗(CRT)的患者。
Neth Heart J. 2006 Jan;14(1):14-18.
2
Scar burden, not intraventricular conduction delay pattern, is associated with outcomes in ischemic cardiomyopathy patients receiving cardiac resynchronization therapy.瘢痕负荷而非室内传导延迟模式与接受心脏再同步治疗的缺血性心肌病患者的结局相关。
Heart Rhythm. 2018 Nov;15(11):1664-1672. doi: 10.1016/j.hrthm.2018.05.027. Epub 2018 May 28.
3
Novel approach to discriminate left bundle branch block from nonspecific intraventricular conduction delay using pacing-induced functional left bundle branch block.利用起搏诱发功能性左束支传导阻滞鉴别左束支传导阻滞与非特异性室内传导延迟的新方法。
J Interv Card Electrophysiol. 2018 Dec;53(3):347-355. doi: 10.1007/s10840-018-0449-5. Epub 2018 Sep 19.
4
Gender, underutilization of cardiac resynchronization therapy, and prognostic impact of QRS prolongation and left bundle branch block in heart failure.性别、心脏再同步治疗的未充分利用以及心力衰竭中QRS波增宽和左束支传导阻滞的预后影响
Europace. 2015 Mar;17(3):424-31. doi: 10.1093/europace/euu205. Epub 2014 Aug 27.
5
T-wave area predicts response to cardiac resynchronization therapy in patients with left bundle branch block.T波面积可预测左束支传导阻滞患者对心脏再同步治疗的反应。
J Cardiovasc Electrophysiol. 2015 Feb;26(2):176-83. doi: 10.1111/jce.12549. Epub 2014 Oct 20.
6
Assessment of cardiac resynchronisation therapy in patients with wide QRS and non-specific intraventricular conduction delay: rationale and design of the multicentre randomised NICD-CRT study.宽QRS波与非特异性室内传导延迟患者心脏再同步治疗的评估:多中心随机NICD-CRT研究的原理与设计
BMJ Open. 2016 Nov 11;6(11):e012383. doi: 10.1136/bmjopen-2016-012383.
7
New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and left ventricular ejection fraction response to guideline-directed therapies: The NEOLITH study.新出现的左束支传导阻滞相关特发性非缺血性心肌病和左心室射血分数对指南指导治疗的反应:NEOLITH 研究。
Heart Rhythm. 2016 Apr;13(4):933-42. doi: 10.1016/j.hrthm.2015.12.020. Epub 2015 Dec 11.
8
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).多中心自动除颤器植入试验-心脏再同步治疗(MADIT-CRT)中 QRS 形态对心脏再同步治疗效果的影响。
Circulation. 2011 Mar 15;123(10):1061-72. doi: 10.1161/CIRCULATIONAHA.110.960898. Epub 2011 Feb 28.
9
Predicting response to cardiac resynchronization therapy: Use of strict left bundle branch block criteria.预测心脏再同步治疗的反应:严格左束支传导阻滞标准的应用。
Pacing Clin Electrophysiol. 2019 Apr;42(4):431-438. doi: 10.1111/pace.13638. Epub 2019 Feb 28.
10
Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14,713 patients in the Swedish Heart Failure Registry.年龄、QRS 波群延长和左束支传导阻滞的预后影响,以及心脏再同步治疗的应用:来自瑞典心力衰竭注册研究的 14713 例患者的研究结果。
Eur J Heart Fail. 2014 Oct;16(10):1073-81. doi: 10.1002/ejhf.162. Epub 2014 Sep 8.

引用本文的文献

1
Eligibility for cardiac resynchronization therapy in patients hospitalized with heart failure.心力衰竭住院患者心脏再同步治疗的适应证。
ESC Heart Fail. 2018 Aug;5(4):668-674. doi: 10.1002/ehf2.12297. Epub 2018 Jun 25.

本文引用的文献

1
Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society.心脏再同步治疗的患者选择:来自临床心脏病学委员会心电图与心律失常小组委员会以及医疗质量与结果研究跨学科工作组,并与心律协会合作。
Circulation. 2005 Apr 26;111(16):2146-50. doi: 10.1161/01.CIR.0000161276.09685.4A.
2
Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial.多中心非持续性心动过速试验中心律失常性死亡和总死亡率的心电图预测因素
Circulation. 2004 Aug 17;110(7):766-9. doi: 10.1161/01.CIR.0000139311.32278.32. Epub 2004 Aug 2.
3
Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal.心脏再同步治疗的超声心动图评估:是否已准备好用于常规临床应用?一项批判性评估。
J Am Coll Cardiol. 2004 Jul 7;44(1):1-9. doi: 10.1016/j.jacc.2004.02.055.
4
Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography.心脏再同步治疗后左心室功能的改善可通过组织多普勒成像超声心动图预测。
Circulation. 2004 Mar 2;109(8):978-83. doi: 10.1161/01.CIR.0000116765.43251.D7. Epub 2004 Feb 9.
5
Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients.左心室内机电不同步。心力衰竭患者严重心脏事件的一个新的独立预测指标。
J Am Coll Cardiol. 2004 Jan 21;43(2):248-56. doi: 10.1016/j.jacc.2003.08.038.
6
Prevalence of QRS prolongation in a community hospital cohort of patients with heart failure and its relation to left ventricular systolic dysfunction.社区医院心力衰竭患者队列中QRS波增宽的患病率及其与左心室收缩功能障碍的关系。
Am J Cardiol. 2004 Jan 15;93(2):244-6. doi: 10.1016/j.amjcard.2003.09.053.
7
Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS.心脏再同步治疗对难治性心力衰竭和“窄”QRS波患者的长期疗效
J Am Coll Cardiol. 2003 Dec 17;42(12):2117-24. doi: 10.1016/j.jacc.2003.08.024.
8
Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay.根据心室传导延迟严重程度分层的心力衰竭患者中使用左心室起搏的心脏再同步治疗的临床疗效。
J Am Coll Cardiol. 2003 Dec 17;42(12):2109-16. doi: 10.1016/j.jacc.2003.04.003.
9
Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.在一项针对窦房结功能障碍的起搏器治疗临床试验中,心室起搏对基线QRS时限正常患者的心力衰竭和心房颤动的不良影响。
Circulation. 2003 Jun 17;107(23):2932-7. doi: 10.1161/01.CIR.0000072769.17295.B1. Epub 2003 Jun 2.
10
Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.晚期慢性心力衰竭患者联合心脏再同步化治疗与植入式心脏复律除颤治疗:MIRACLE ICD试验
JAMA. 2003 May 28;289(20):2685-94. doi: 10.1001/jama.289.20.2685.